San Francisco, California, United StatesFounded 202120+ employeesPrivate
$29.5M raisedSeed· last: seed (Sep 2025)· 4 rounds
Backed by(7 investors)
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.
